Skip to Main Content

Paper Details

Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.
Hypertension
16
2021
Hypertensive, Patients
Author NameAffiliation
Harlan M KrumholzYale University School of Medicine
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Harlan M KrumholzYale University School of Medicine
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Marc A SuchardFielding School of Public Health (M.A.S.
Marc A SuchardDavid Geffen School of Medicine at University of California los angeles
Marc A SuchardFielding School of Public Health (M.A.S.
Marc A SuchardDavid Geffen School of Medicine at University of California los angeles
Martijn J SchuemieFielding School of Public Health (M.A.S.
Martijn J Schuemie
Martijn J SchuemieFielding School of Public Health (M.A.S.
Martijn J Schuemie
George HripcsakColumbia University Irving Medical Center
George HripcsakNew York-Presbyterian Hospital (G.H.).
George HripcsakColumbia University Irving Medical Center
George HripcsakNew York-Presbyterian Hospital (G.H.).
Ruijun ChenColumbia University Irving Medical Center
Ruijun ChenWeill Cornell Medical College
Jon DukeGeorgia Tech Research Institute, Georgia Tech College of Computing
Jon DukeGeorgia Tech Research Institute, Georgia Tech College of Computing
Nicole L PrattQuality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia
Nicole L PrattQuality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia
Christian Reich
Christian Reich
David MadiganColumbia University
David MadiganColumbia University
Patrick B Ryan
Patrick B RyanColumbia University Irving Medical Center
Patrick B Ryan
Patrick B RyanColumbia University Irving Medical Center
  • 1 - 30

Datasets

Release 1.2